Stay updated on Satralizumab in Generalized Myasthenia Gravis Clinical Trial

Sign up to get notified when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-05-01T19:34:50.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study information regarding satralizumab for generalized myasthenia gravis and the update of the revision number from v2.14.4 to v2.15.0.
    Difference
    6%
    Check dated 2025-04-17T06:56:51.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding two new dates: February 19, 2025, and February 28, 2025.
    Difference
    0.3%
    Check dated 2025-04-09T23:27:45.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new revision version (v2.14.3) and the dates for the results and last update have been changed to more recent ones, indicating a shift in the timeline of information provided.
    Difference
    0.3%
    Check dated 2025-04-01T18:51:25.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The study has been terminated, and the sponsor has decided to halt development of satralizumab in generalized myasthenia gravis. Additionally, the number of study locations has decreased from 86 to 76, and several specific locations have been updated or removed.
    Difference
    100%
    Check dated 2025-03-03T22:19:13.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:37:37.000Z thumbnail image

Stay in the know with updates to Satralizumab in Generalized Myasthenia Gravis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.